Search Results - "Barber, Beth"

Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data by Ma, Qiufei, Shilkrut, Mark, Zhao, Zhongyun, Li, Minming, Batty, Nicolas, Barber, Beth

“…Immunotherapies have advanced the treatment of metastatic melanoma; however, they are associated with immune-related toxicities. Patients with pre-existing…”
Get full text

The cost of treating skeletal-related events in patients with prostate cancer by Lage, Maureen J, Barber, Beth L, Harrison, David J, Jun, Sun

“…To examine the economic burden of skeletal-related events (SREs) and to assess the frequency of different types of SREs in this population. Retrospective…”
Get full text

Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective by Jakubowiak, Andrzej J, Campioni, Marco, Benedict, Ágnes, Houisse, Ivan, Tichy, Eszter, Giannopoulou, Andromachi, Aggarwal, Sanjay K, Barber, Beth L, Panjabi, Sumeet

“…To assess the economic value of carfilzomib (Kyprolis), this study developed the Kyprolis Global Economic Model (K-GEM), which examined from a United States…”
Get more information

Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis by Ma, Qiufei, Zhao, Zhongyun, Barber, Beth L., Shilkrut, Mark

“…Introduction Isolated limb perfusion and infusion (ILP/ILI) are therapies for regional metastatic melanoma that allow high doses of anticancer drugs to be…”
Get full text

Utilities and Disutilities for Type 2 Diabetes Treatment-Related Attributes by Matza, Louis S., Boye, Kristina S., Yurgin, Nicole, Brewster-Jordan, Jessica, Mannix, Sally, Shorr, Jodi M., Barber, Beth L.

“…Introduction Although cost-utility analyses are frequently used to estimate treatment outcomes for type 2 diabetes, utilities are not available for key…”
Get full text

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy by Vera-Llonch, Montserrat, Weycker, Derek, Glass, Andrew, Gao, Sue, Borker, Rohit, Barber, Beth, Oster, Gerry

“…To characterize healthcare resource utilization and costs in patients with metastatic lung cancer receiving chemotherapy in the US. Using data from a large…”
Get full text

Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-Type KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy by Graham, Christopher N., MS, Maglinte, Gregory A., PhD, Schwartzberg, Lee S., MD, FACP, Price, Timothy J., MBBS, DHlthSc (Medicine), FRACP, Knox, Hediyyih N., MA, Hechmati, Guy, MD, MSc, Hjelmgren, Jonas, MSc, Barber, Beth, PhD, Fakih, Marwan G., MD

“…Abstract Purpose In this analysis, we compared costs and explored the cost-effectiveness of subsequent-line treatment with cetuximab or panitumumab in patients…”
Get full text

Acute Stress, Depression, and Anxiety Symptoms Among English and Spanish Speaking Children with Recent Trauma Exposure by Barber, Beth A., Kohl, Krista L., Kassam-Adams, Nancy, Gold, Jeffrey I.

“…A growing literature suggests the clinical importance of acute stress disorder symptoms in youth following potentially traumatic events. A multisite sample of…”
Get full text

Treatment Patterns in Patients with Metastatic Melanoma: A Retrospective Analysis by Zhao, Zhongyun, Barber, Beth L., Wang, Song

“…Objective. To describe treatment patterns and factors influencing treatment in a real-world setting of US patients with metastatic melanoma (MM). Methods. This…”
Get full text

Neurocognitive Functioning in Children with Obstructive Sleep Apnea Syndrome: A Pilot Study of Positive Airway Pressure Therapy by Yuan, Harry C., Sohn, Eugene Y., Abouezzeddine, Tania, Mahrer, Nicole E., Barber, Beth A., Keens, Thomas G., Davidson Ward, Sally L., Gold, Jeffrey I.

“…Studies of individuals with obstructive sleep apnea syndrome (OSAS) have shown impairment in neurocognitive function. This study investigated the…”
Get full text

Olanzapine versus risperidone in the treatment of schizophrenia: A comparison of costs among Texas Medicaid recipients by RASCATI, Karen L, JOHNSRUD, Michael T, CRISMON, M. Lynn, LAGE, Maureen J, BARBER, Beth L

“…To examine both schizophrenia-related costs and total (schizophrenia plus non-schizophrenia) healthcare costs among Texas Medicaid recipients who had been…”
Get full text

Cost-Effectiveness of Early versus Late Cinacalcet Treatment in Addition to Standard Care for Secondary Renal Hyperparathyroidism in the USA by Ray, Joshua A., MSc, Borker, Rohit, PhD, Barber, Beth, PhD, Valentine, William J., PhD, Belozeroff, Vasily, PhD, Palmer, Andrew J., MBBS

“…Abstract Objectives The objective of this research was to estimate lifetime cost-effectiveness of treating patients with cinacalcet early (when parathyroid…”
Get full text

Costs of hospital events in patients with metastatic colorectal cancer by Overbeek, Jetty A, Zhao, Zhongyun, van Herk-Sukel, Myrthe P P, Barber, Beth L, Gao, Sue, Herings, Ron M C

“…In the last decade, the number of new agents, including monoclonal antibodies, being developed to treat metastatic colorectal cancer (mCRC) increased rapidly…”
Get more information

A multirater validation study to assess the reliability of acne lesion counting by Lucky, Anne W, Barber, Beth L, Girman, Cynthia J, Williams, Jody, Ratterman, Joan, Waldstreicher, Joanne

“…Background: Despite widespread use of acne lesion counting, little has been published on its reliability, particularly for multiple raters. Objective: Our…”
Get full text

Overall survival in patients with metastatic melanoma by Song, Xue, Zhao, Zhongyun, Barber, Beth, Farr, Amanda M., Ivanov, Boris, Novich, Marilyn

“…Abstract Introduction: Patients with regionally or distantly metastatic melanoma have poor long-term prognosis. The objective of this analysis was to describe…”
Get full text

Economic outcomes associated with Switching individuals with schizophrenia between risperidone and olanzapine: Findings from a large US claims database by ZHONGYUN ZHAO, NAMJOSHI, Madhav, BARBER, Beth L, LOOSBROCK, Danielle L, TUNIS, Sandra L, BAOJIN ZHU, BREIER, Alan

“…To assess the impact of switching atypical antipsychotic treatment [from (i) risperidone to olanzapine or (ii) olanzapine to risperidone] on medication use…”
Get full text

Population preference values for health states in relapsed or refractory B-precursor acute lymphoblastic leukemia in the United Kingdom by Aristides, Mike, Barlev, Arie, Barber, Beth, Gijsen, Merel, Quinn, Casey

“…To date, reliable and comprehensive health-related quality of life data for patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL)…”
Get full text

Economic burden of toxicities associated with treating metastatic melanoma in eight countries by Wehler, Elizabeth, Zhao, Zhongyun, Bilir, S. Pinar, Munakata, Julie, Barber, Beth

“…Background Information on costs of managing adverse events (AEs) associated with current treatments in metastatic melanoma is limited. This study estimates…”
Get full text

Impact of abciximab versus eptifibatide on length of hospital stay for PCI patients by Lage, Maureen J., Barber, Beth L., McCollam, Patrick L., Bala, Mohan, Scherer, Joel

“…The purpose of this study is to compare the profile of percutaneous coronary intervention (PCI) patients who receive abciximab versus eptifibatide, as well as…”
Get full text

Abciximab provides cost-effective survival advantage in high-volume interventional practice by Kereiakes, Dean J., Obenchain, Robert L., Barber, Beth L., Smith, Andrew, McDonald, Mark, Broderick, Thomas M., Runyon, John Paul, Shimshak, Thomas M., Schneider, John F., Hattemer, Charles R., Roth, Eli M., Whang, David D., Cocks, Douglas, Abbottsmith, Charles W.

“…Background Placebo-controlled randomized trials of platelet glycoprotein (GP) IIb/IIIa blockade during percutaneous coronary intervention have demonstrated…”
Get full text